Articles published by Alvotech
Positive Top Line Results from Confirmatory Efficacy Study for Proposed Biosimilar to Xolair® (omalizumab)
Today 4:00 EDT
From Alvotech
Via GlobeNewswire
Tickers
ALVO
From Alvotech
Via GlobeNewswire
Tickers
ALVO

Alvotech Meets Investors and Presents at the Goldman Sachs Global Healthcare Conference in Miami
June 06, 2025
From Alvotech
Via GlobeNewswire
Tickers
ALVO



Alvotech Meets Investors and Presents at the Jefferies Global Healthcare Conference 2025 in New York, NY
June 02, 2025
From Alvotech
Via GlobeNewswire
Tickers
ALVO

From Alvotech
Via GlobeNewswire
Tickers
ALVO
Alvotech Announces Webcast of First Quarter 2025 Financial Results on May 8, 2025, at 8:00 am EDT
May 02, 2025
From Alvotech
Via GlobeNewswire
Tickers
ALVO
From Alvotech
Via GlobeNewswire
Tickers
ALVO
From Alvotech
Via GlobeNewswire
Tickers
ALVO



From Alvotech
Via GlobeNewswire
Tickers
ALVO

Alvotech Reports Financial Results for the First Nine Months of 2024
November 13, 2024
From Alvotech
Via GlobeNewswire
Tickers
ALVO




Alvotech Meeting Investors and Presenting at the Jefferies 2024 London Healthcare Conference on November 19–20, 2024
October 25, 2024
From Alvotech
Via GlobeNewswire
Tickers
ALVO


Alvotech Initiates Confirmatory Patient Study for AVT16, a Proposed Biosimilar to Entyvio®
September 25, 2024
From Alvotech
Via GlobeNewswire
Tickers
ALVO

Alvotech to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
August 26, 2024
From Alvotech
Via GlobeNewswire
Tickers
ALVO

Alvotech Reports Record Revenues and Adjusted EBITDA for the Second Quarter and First Six Months of 2024
August 15, 2024
From Alvotech
Via GlobeNewswire
Tickers
ALVO
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.